Clinical Trial Update: Nitric Oxide Releasing Solution (NORS) For The Treatment Of Human Papillomavirus(HPV) Verrucae Plantaris (Plantar Warts) [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for a nitric oxide releasing solution (NORS) aimed at treatment of plantar warts due to HPV Verruca Plantaris.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Verruca Plantaris

Drugs mentioned

• Nitric Oxide Releasing Solution (NORS)

Snippet

Sponsor: Sanotize Research and Development corp. | Conditions: Verruca Plantaris | Phase 2 | Status: COMPLETED